Cardiometabolic Health Congress

JUNE 24, 2024

As a leader in the field of research-based cardiometabolic health education, CMHC is proud to present its CME education outcomes study at ADA (American Diabetes Association) 2024 Scientific Sessions, which offers its education-focused agenda to a wide number of healthcare practitioners from all areas of the U.S.

Patient Care 52

Patient Care Obesity Education CME 52

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.

Atrial Fibrillation 92

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 92

Cardiometabolic Health Congress

NOVEMBER 8, 2023

2023, the American Heart Association (AHA) issued a presidential advisory on the urgency of this systemic disorder involving heart disease, kidney disease, diabetes and obesity. The virtual, self-paced Foundations of Cardiometabolic Health Certificate Course is the first step to attaining the CCHP credential.

Certification 52

Certification Nursing Kidney Disease Education 52

Cardiometabolic Health Congress

AUGUST 14, 2024

The focus will be on the intricate interplay between cardiorenal and metabolic conditions, such as type 2 diabetes, cardiovascular disease, and chronic kidney disease, driven by lifestyle and health factors. Singh, MBBS, FRCP, MBA Advances in Obesity Pharmacotherapy Louis J. Contact Data Megan Magana, Sr.

CME 72

CME Education Diabetes Innovation 72

European Journal of Heart Failure

DECEMBER 22, 2023

1.65), chronic kidney disease (HR 1.37, 95%CI 1.34-1.41), 1.41), chronic obstructive pulmonary disease (HR 1.32, 95%CI 1.28-1.35). Obesity was associated with a lower risk of all-cause death (HR 0.81, 95%CI 0.79-0.84). The highest risk was associated with dementia (hazard ratio [HR] 1.55, 95% confidence interval [CI] 1.45-1.65),

Heart Failure 40

Heart Failure Coronary Artery Disease Kidney Disease Dementia 40

Stroke Journal

FEBRUARY 1, 2024

We compared demographics, hospital traits, comorbidities, and outcomes. In-hospital mortality, our primary outcome, was analyzed through multivariate logistic regression using STATA 18.Results:Incorporating to 2.26) and liver disease (OR 2.20, p < 0.01, CI 1.27

Inpatient 40

Inpatient Strokes Stroke Coronary Artery Disease 40

DAIC

SEPTEMBER 11, 2024

A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.

Atrial Fibrillation 52

Atrial Fibrillation Quality of Life Myocardial Infarction Kidney Disease 52

Cardiometabolic Health Congress

SEPTEMBER 13, 2024

Measuring eGFR and albuminuria is recommended for assessing kidney disease in all hypertensive patients. Philip Moons (Belgium) presented the first results showing that patient-reported outcomes (PROs) vary significantly across different heart defects, and anatomical complexity is a poor predictor of PROs. Watch here!

Hypertension 59

Hypertension Cardiovascular Disease Bicuspid/Mitral Arrhythmia 59

GEMMS

MAY 22, 2024

This improves diagnostic accuracy and ultimately leads to better patient outcomes. Artificial Intelligence Artificial intelligence (AI) has revolutionized cardiac diagnosis by allowing for the analysis of extensive patient data to identify patterns and predict outcomes.

Heart Disease 52

Heart Disease Blood Pressure Technology Innovation 52

DAIC

DECEMBER 8, 2023

“The new guideline reinforces the urgent need to approach AFib as a complex cardiovascular condition that requires disease prevention, risk factor modification, as well as optimizing therapies and patients’ access to care and ongoing, long-term management.” For example, kidney disease is not included in CHA 2 DS 2 -VASc.

Atrial Fibrillation 52

Atrial Fibrillation AFIB Strokes Stroke 52

DAIC

JANUARY 23, 2024

5 Over my career as a cardiovascular surgeon, as well as an immunologist, I have witnessed how current treatments for ASCVD have led to considerable improvements in outcomes, yet many patients remain vulnerable to life-threatening cardiac events.1,6 34 The safety of colchicine, 0.5 μ/L on 0.6

Cardiovascular Disease 111

Cardiovascular Disease Heart Attack Heart attacks Coronary Artery Disease 111

Physiologically Speaking

DECEMBER 15, 2023

Participating in any resistance training is associated with a 15%–17% lower risk for these outcomes compared to non-participation. For adults with overweight and obesity, resistance exercise increases lean body mass and reduces body fat percentage and fat mass — improving overall body composition.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

DECEMBER 15, 2023

Participating in any resistance training is associated with a 15%–17% lower risk for these outcomes compared to non-participation. For adults with overweight and obesity, resistance exercise increases lean body mass and reduces body fat percentage and fat mass — improving overall body composition.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Cardiometabolic Health Congress

DECEMBER 7, 2023

This is due to several factors, including the aging of the population, a rise in obesity, increased detection, and increased survival with AF along with other forms of CVD. By 2030, it is estimated that AF prevalence in the United States will rise to 12.1 million.

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Strokes 111

Physiologically Speaking

MAY 3, 2024

1 For the study, male and female rats underwent endurance exercise training for 1, 2, 4, or 8 weeks and had over 18 different tissues harvested 48 hours after their last exercise bout (this was done to prevent the acute influence of exercise on study outcomes).

Exercise 95

Exercise Physiology Research Kidney Disease 95

Cardiometabolic Health Congress

JUNE 29, 2023

Because CMHC is committed to forging relationships with organizations that share a pursuit of bettering patient outcomes through unparalleled provider education, many like-minded regional and national organizations will be in attendance.

Peripheral Arterial Disease 40

Peripheral Arterial Disease Education Webinar Kidney Disease 40

Cardiometabolic Health Congress

NOVEMBER 14, 2024

With the holiday season approaching and fall in full swing, it’s the perfect time to reaffirm our commitment to delivering excellent care, improving patient outcomes, and making the most of every available resource. Cardiovascular disease remains the leading cause of death worldwide , claiming 18 million lives annually.

CME 103

CME Obesity Heart Failure Biomarkers 103